Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines

Tumor Biology

Volumn 34, Issue 1, 2013, Pages 203-214

  Vesper, B J ^a   Onul, A ^a   Haines III, G K ^b   Tarjan, G ^c   Xue, J ^a   Elseth, K M ^a   Aydogan, B ^a,d   Altman, M B ^a,d   Roeske, J C ^e   Paradise, W A ^a   De Vitto, H ^a,f   Radosevich, J A ^a,g  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Jr Hospital of Cook County   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Breast cancer; Nitric oxide (NO); Nitric oxide synthase (NOS); Reactive Nitrogen Species (RNS); Reactive Oxygen Species (ROS)

Indexed keywords

GLUTATHIONE TRANSFERASE P1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN P53;

ARTICLE; BREAST ADENOCARCINOMA; CELL ACTIVITY; CELL CYCLE; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; TUMOR CELL LINE; TUMOR GROWTH; TUMOR RESISTANCE; ULTRAVIOLET RADIATION; UPREGULATION; X RAY;

EID: 84872783522     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0530-0     Document Type: Article

References (59)

1. American Cancer Society Inc., Breast Cancer Facts & Figures 2011-2012. Copyright 2011 [Accessed 27 March 2012]; Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-030975.pdf.
2. A Jemal, et al. 2011 Global cancer statistics CA: A Cancer Journal for Clinicians 61 2 69 90 10.3322/caac.20107
3. Bentz BG, et al. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 1999;108(8):781-7.
4. C Nathan QW Xie 1994 Nitric oxide synthases: roles, tolls, and controls Cell 78 6 915 918 7522969 10.1016/0092-8674(94)90266-6 1:CAS:528: DyaK2cXmsV2jsLg%3D
5. S Singh, et al. 2009 The impact of intracellular generation of nitric oxide on the radiation response of human tumor cells Radiat Res 171 5 572 80 19580492 10.1667/RR1640.1 1:CAS:528:DC%2BD1MXlvVCqs7k%3D
6. WA Paradise BJ Vesper A Goel JD Waltonen KW Altman GK Haines III JA Radosevich 2010 Nitric oxide: perspectives and emerging studies of a well known cytotoxin Int J Mol Sci 11 2715 2745 20717533 10.3390/ijms11072715 1:CAS:528:DC%2BC3cXptF2hsLk%3D
7. BJ Vesper, et al. 2010 Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide Tumor Biol 31 4 267 75 10.1007/s13277-010- 0028-6 1:CAS:528:DC%2BC3cXns1Cku7w%3D
8. BG Bentz, et al. 2004 Nitrosative stress induces DNA strand breaks but not caspase mediated apoptosis in a lung cancer cell line J Carcinog 3 1 16 15617570 10.1186/1477-3163-3-16
9. BG Bentz, et al. 1997 Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial carcinomas Tumor Biol 18 5 290 300 10.1159/000218042 1:STN:280:DyaK2svitF2isA%3D%3D
10. BG Bentz, et al. 1998 Endothelial constitutive nitric oxide synthase (ecNOS) localization in normal and neoplastic salivary tissue Head Neck 20 4 304 309 9588702 10.1002/(SICI)1097-0347(199807)20:4<304::AID-HED4>3.0.CO;2-2 1:STN:280:DyaK1c3kvVWitA%3D%3D
11. BG Bentz, et al. 2007 The kinetics and redox state of nitric oxide determine the biological consequences in lung adenocarcinoma Tumor Biol 28 6 301 11 10.1159/000115526 1:CAS:528:DC%2BD1cXkvFCrsL8%3D
12. BG Bentz, et al. 2000 The yin and yang of nitric oxide: reflections on the physiology and pathophysiology of NO Head Neck 22 1 71 83 10585608 10.1002/(SICI)1097-0347(200001)22:1<71::AID-HED11>3.0.CO;2-G 1:STN:280:DC%2BD3c%2FlsVensw%3D%3D
13. I Keydar, et al. 1979 Establishment and characterization of a cell line of human breast carcinoma origin Eur J Cancer 15 5 659 670 228940 1:CAS:528:DyaE1MXkslartL4%3D
14. SS Beevi MH Rasheed A Geetha 2007 Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma Clin Chim Acta 375 1-2 119 23 16889762 10.1016/j.cca.2006.06.028 1:CAS:528:DC%2BD28XhtFWiu7rM
15. S Loibl, et al. 2002 Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy Cancer 95 6 1191 8 12216084 10.1002/cncr.10817 1:CAS:528:DC%2BD38XnvVSrsrs%3D
16. A Duenas-Gonzalez, et al. 1997 Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease Mod Pathol 10 7 645 9 9237172 1:STN:280:DyaK2szotVersQ%3D%3D
17. W Tschugguel, et al. 1999 Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade Breast Cancer Res Treat 56 2 145 51 10573107 10.1023/A:1006288526311 1:CAS:528:DyaK1MXnvVKitr8%3D
18. CS Cobbs, et al. 1994 Expression of nitric oxide synthase in human central nervous system tumors Cancer Res 55 4 727 730
19. R Chandra, et al. 2001 Expression of nitric oxide synthase type 3 in reflux-induced esophageal lesions. Otolaryngol Head Neck Surg 124 4 442 447 10.1067/mhn.2001.114254 1:STN:280:DC%2BD3MzjvF2rtA%3D%3D
20. S Ambs, et al. 1998 Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression Cancer Res 58 2 334 341 9443414 1:CAS:528:DyaK1cXnt1ajtA%3D%3D
21. YK Chen SS Hsue LM Lin 2002 Increased expression of inducible nitric oxide synthase for human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies Head Neck 24 10 925 32 12369071 10.1002/hed.10131
22. JB Hibbs, et al. 1988 Nitric oxide: a cytotoxic activated macrophage effector molecule Biochem Biophys Res Commun 157 1 87 94 3196352 10.1016/S0006-291X(88)80015-9 1:CAS:528:DyaL1MXntlOisw%3D%3D
23. Hibbs JB, Vavrin A, Taintor RR. l-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 1987;138(2):550-65.
24. S Loibl, et al. 2005 The role of early expression of inducible nitric oxide synthase in human breast cancer Eur J Cancer 41 2 265 71 15661552 10.1016/j.ejca.2004.07.010 1:CAS:528:DC%2BD2MXmvFWisA%3D%3D
25. Miller, L.P. Quantifying western blots without expensive commercial quantification software. Copyright 2007. [Accessed 20 May 2010]; Available from: http://www.lukemiller.org/journal/2007/08/quantifying-western-blots -.
26. MB Altman, et al. 2009 Characterization of a novel phantom for three-dimensional in vitro cell experiments Phys Med Biol 54 5 N75 82 19182327 10.1088/0031-9155/54/5/N02
27. N Natarajan, et al. 1994 Adaptation of the diphenylamine (DPA) assay to a 96-well plate tissue culture format and comparison with the MTT assay BioTechniques 17 1 166 171 7946300 1:CAS:528:DyaK2cXmtVSjsrc%3D
28. Smyth, G.K., et al., Limma: Linear Models for Microarray Data. Bioinformatics and computationalbBiology solutions using R and bioconductor, 2005: 397-420.
29. ME Ritchie, et al. 2007 A comparison of background correction methods for two-colour microarrays Bioinformatics 23 20 2700 7 17720982 10.1093/bioinformatics/btm412 1:CAS:528:DC%2BD2sXht1KmtLjM
30. GK Smyth T Speed 2003 Normalization of cDNA microarray data Methods 31 4 265 73 14597310 10.1016/S1046-2023(03)00155-5 1:CAS:528:DC%2BD3sXos1Chur4%3D
31. Smyth, G.K., Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol, 2004. 3: Article3.
32. NM Blackett, et al. 1974 Radiation modifying effect of the free radical norpseudopelletierene-N-oxyl on normal bone marrow stem cells in vitro and in vivo Radiat Res 58 3 361 72 10876627 10.2307/3573906 1:CAS:528: DyaE2cXkslCjtb0%3D
33. Bristow, R.G. and R.P. Hill, Molecular and cellular basis of radiotherapy. In I.F. Tannock and R.P. Hill, editors. The basic science of oncology. 1998, McGraw-Hill: New York. p. 95-321.
34. Chen HHW, et al. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy. Int J Radiation Oncology Biol Phys. 2005;63(4):1093-100.
35. BC Cooke EM Fielden M Johnson 1976 Polyfunctional radiosensitizers: I. Effects of a nitroxyl biradical on the survival of mammalian cells in vitro Radiat Res 65 1 152 62 1246563 10.2307/3574295 1:CAS:528:DyaE28XmvFehtA%3D%3D
36. M De Ridder, et al. 2008 Hypoxic tumor cell radiosensitization through nitric oxide Nitric Oxide 19 2 164 9 18474256 10.1016/j.niox.2008.04.015
37. R George, et al. 2006 Audio-visual biofeedback for respiratory-gated radiotherapy: impact of audio instruction and audio-visual biofeedback on respiratory-gated radiotherapy Int J Radiat Oncol Biol Phys 65 3 924 33 16751075 10.1016/j.ijrobp.2006.02.035
38. RJ Griffin, et al. 1996 Radiosensitization of hypoxic tumor cells in vitro by nitric oxide Int J Radiat Oncol Biol Phys 36 2 377 83 8892463 10.1016/S0360-3016(96)00329-X 1:CAS:528:DyaK28XmvFWjtLk%3D
39. Hogle WP. Radiation therapy in the treatment of breast cancer. Semin Oncol Nurs. 2007;23(1):20-8.
40. American Cancer Society, I. Oral Cancer. Copyright 2008 [Accessed 17 June 2012]; Available from: http://www.cancer.org/downloads/PRO/OralCancer.pdf.
41. YZ Wang, et al. 2005 Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA World J Gastroenterol 11 1 46 50 15609395 1:CAS:528:DC%2BD2MXht1Gmtb8%3D
42. Glynn, S., et al., iNOS expression is associated with basal-like breast cancer phenotype and predicts poor survival in ERneg breast cancer. Nitric Oxide, 2007. 17(Supp. 1): S17.
43. Y Nakamura, et al. 2006 Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis Clin Cancer Res 12 4 1201 7 16489074 10.1158/1078-0432.CCR-05-1269 1:CAS:528:DC%2BD28XhsFaltL0%3D
44. Thomsen LL, et al. Nitric oxide synthase in human breast cancer. Br J Cancer. 1995;72(1):41-4.
45. AS Bulut, et al. 2005 Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases Virchows Arch 447 1 24 30 15947943 10.1007/s00428-005-1250-2 1:CAS:528:DC%2BD2MXmt1Gnsrk%3D
46. FA Masri, et al. 2005 Abnormalities in nitric oxide and its derivatives in lung cancer Am J Respir Crit Care Med 172 5 597 605 15947282 10.1164/rccm.200411-1523OC
47. TW Lee, et al. 2003 Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma Eur J Cancer 39 9 1296 301 12763220 10.1016/S0959-8049(02)00733-5 1:CAS:528:DC%2BD3sXjvFelurY%3D
48. CY Liu, et al. 1998 Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer Br J Cancer 78 4 534 41 9716040 10.1038/bjc.1998.528 1:CAS:528: DyaK1cXlslWjurY%3D
49. KW Rosbe, et al. 1995 Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. otolaryngol Head Neck Surg 113 5 541 549 1:STN:280:DyaK28%2FmvVKisw%3D%3D
50. Y Yarmolyuk, et al. 2011 A model system for dtudying nitric oxide in tumors: high nitric oxide-adapted head and neck squamous cell lines Tumor Biol 32 1 77 85 10.1007/s13277-010-0101-1 1:CAS:528:DC%2BC3cXhsFOiurfP
51. BG Bentz, et al. 2002 Nitric oxide and apoptosis during human head and neck squamous cell carcinoma development Am J Otolaryngol 23 1 4 11 11791242 10.1053/ajot.2002.28772 1:CAS:528:DC%2BD38Xht1ykt74%3D
52. J Gavilanes, et al. 1999 Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck Laryngoscope 109 1 148 152 9917057 10.1097/00005537-199901000-00028 1:CAS:528:DyaK1MXpsVSitg%3D%3D
53. BG Bentz GK Haines III JA Radosevich 2000 Glutathione S-transferase pi in squamous cell carcinoma of the head and neck Laryngoscope 110 10 Pt 1 1642 1647 11037818 10.1097/00005537-200010000-00013 1:CAS:528:DC%2BD3cXnsVOjsrg%3D
54. KJ Cullen, et al. 2003 Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors Cancer Res 63 23 8097 102 14678959 1:CAS:528:DC%2BD3sXpvVagsb4%3D
55. H Shiga, et al. 1999 Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer Clin Cancer Res 5 12 4097 104 10632346 1:CAS:528: DC%2BD3cXlsV2gsg%3D%3D
56. DF Dourado A Fernandes MJ Ramos 2008 Mammalian cytosolic glutathione transferases Curr Protein Pept Sci 9 4 325 337 18691123 10.2174/ 138920308785132677 1:CAS:528:DC%2BD1cXpsFOmsro%3D
57. TP Mulder, et al. 1995 Glutatione S-transferases and glutathione in human head and neck cancer Carcinogenesis 16 3 619 624 7697822 10.1093/carcin/16.3. 619 1:CAS:528:DyaK2MXkvV2js74%3D
58. De Vitto, et al. Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors. Tumor Biol. 2012. doi: 10.1007/s13277-012-0555-4.
59. De Vitto, et al. Part III. Molecular changes induced by high nitric oxide adaptation in human breast cancer cell line BT-20 (BT-20-HNO): a switch from aerobic to anaerobic. Tumor Biol. 2012. doi: 10.1007/s13277-012-0564-3.